Clinical Trials in Baltimore

Showing 3341-3360 of 23,476 trials

A Study to Investigate HLA-G Targeted Exosome (SOB100) in Healthy Subjects

NCT07219940

The investigational drug, SOB100, is an HLA-G targeted exosome equipped with a nanobody namely anti-HLA-G VHH on the exosome membrane. This is a Phase I dose escalation study to exam the tolerability, safety, and pharmacokinetics in healthy subjects.

Healthy SubjectsExosomeTargeted Therapy

Shine-On Biomedical Co., Ltd.15 participantsStarted Dec 2025

Baltimore, Maryland, United States

Active Not RecruitingPhase 3< 1 mile

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

NCT03432286

The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatment of episodic migraine. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.

Episodic Migraine

Eli Lilly and Company533 participantsStarted Mar 2018

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +70 more locations

A Study to Investigate HLA-G Targeted Exosome (SOB100) in Healthy Subjects

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

Find Trials by Condition in Baltimore

Behavioral and Neural Representations of Subjective Effort Cost

Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

Mirror Neuron Network Dysfunction as an Early Biomarker of Neurodevelopmental Disorder

Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

Pre-Symptomatic Study of Intravenous Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema

Vaccine Immune Recovery After Leukemia

Abatacept for the Treatment of Giant Cell Arteritis

A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia

Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR

Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

Deep Brain Stimulation of Treatment-Resistant Bipolar Depression

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery

Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]

A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy